<DOC>
	<DOCNO>NCT00807300</DOCNO>
	<brief_summary>Percutaneous , image-guided tumor ablation evolve genuine alternative treatment unresectable hepatocellular carcinoma . Published data explore stereotactic proton beam percutaneous irradiation reveal , hepatocellular carcinoma ( HCC ) radiosensitive certain protocol . In Phase I II study , investigator investigate potential role local irradiation primary secondary liver tumor employ Iridium192 source . The promising result previous study indicate CT-guided brachytherapy might play role treatment unresectable HCC . Therefore , investigator start randomize , control , clinical Phase-II study evaluate efficacy survival-benefits brachytherapy versus transarterial chemoembolization patient unresectable HCC .</brief_summary>
	<brief_title>Computed Tomography ( CT ) - Guided Brachytherapy Versus Transarterial Chemoembolization Patients With Unresectable Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>diagnosis HCC histopathology accord criterion Consensus Conference European Association Study Liver Disease unresectable HCC KarnofskyIndex &gt; 70 estimate life expectancy &gt; 16 week adequate bone marrow function adequate contraception female patient informed consent portal vein thrombosis tumor side extrahepatic spread Child C untreated malignant disease general contraindication chemotherapy active infectious disease neuropathy , platinallergy pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>percutaneous treatment</keyword>
</DOC>